PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsIntellectual disability
MeSH D008607 - intellectual disability
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D065886:Neurodevelopmental disorders
0 Companies
0 Drugs
Success rate
D019954:Neurobehavioral manifestations
$
Success rate
D008607: 
Intellectual disability
$
Success rate
D000073839:Trisomy 13 syndrome
0 Companies
0 Drugs
Success rate
D003410:Cri-du-chat syndrome
0 Companies
0 Drugs
Success rate
D003635:De lange syndrome
0 Companies
0 Drugs
Success rate
D004314:Down syndrome
0 Companies
0 Drugs
Success rate
D011218:Prader-willi syndrome
$
Success rate
D012415:Rubinstein-taybi syndrome
0 Companies
0 Drugs
Success rate
D017624:Wagr syndrome
0 Companies
0 Drugs
Success rate
D018980:Williams syndrome
0 Companies
0 Drugs
Success rate
D038901:X-linked mental retardation
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0%
0/3
Phase 2
42%
5/12
Phase 3
11%
1/9
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use